Merck is testing a confluence of potential chart support near the $55 level. The stock of pharmaceutical company Merck (ticker, MRK) has been bloodied a…
Dana Lyons
Does Chart Hold Prescription For Bounce In This Drug Stock? (PREMIUM)
This content is only available to subscribers. Sign up today!
Daily Strategy Session – 11/3/2017 PREMIUM
This content is only available to subscribers. Sign up today!
Bullish Fund Assets On A Stampede (PREMIUM)
This content is only available to subscribers. Sign up today!
Daily Strategy Session – 11/2/2017 PREMIUM
This content is only available to subscribers. Sign up today!
“Remember To Come Back In November”
The compliment to “Sell in May and Go Away” doesn’t have a catchy jingle, but the historically best 6-month stretch of the year for stocks…
Daily Strategy Session – 11/1/2017 PREMIUM
This content is only available to subscribers. Sign up today!
Is Stock Rally Getting Too Thin? (PREMIUM)
This content is only available to subscribers. Sign up today!
Daily Strategy Session – 10/31/2017 PREMIUM
This content is only available to subscribers. Sign up today!
Less Than Meets The Eye To Nasdaq Rally? (PREMIUM)
This content is only available to subscribers. Sign up today!